Global Rank
Daily Visitors
Last scanned
Domain Age
Updated:
REVLIMID® (lenalidomide) - Official Patient Website
Learn more about REVLIMID® (lenalidomide). Please see Indication and Important Safety Information, including Boxed WARNINGS.
This website is hosted with Incapsula Inc, which reserves the following IP addresses for revlimid.com: 45.60.150.161. Moreover, DNS used with this website include ns-1413.awsdns-48.org, ns-1716.awsdns-22.co.uk, ns-240.awsdns-30.com, ns-650.awsdns-17.net. Subnet identifier ranges from 45.60.0.0 to 45.60.255.255. Classless Inter-Domain Routing (CIDR) is 45.60.0.0/16. ARIN net type is Direct Allocation.
Global Rank
Daily Visitors
Last scanned
Domain Age
ns-1413.awsdns-48.org
ns-1716.awsdns-22.co.uk
ns-240.awsdns-30.com
ns-650.awsdns-17.net
{{value}}
2003-08-19
2024-08-19
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of revlimid.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-08-19. According to open source data, you can reach the owner at dns.admin@BMS.COM but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
N/A
N/A
N/A
6.9K
9.4K
6.7K
8.2K
N/A
133